Skip to main content
- Funds
- Insights
- Capabilities
- About Us
- My Account
The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
Dr. Ken Song, President and CEO of RayzeBio, discusses the company’s innovative approach to radiopharmaceuticals and highlights how Wellington’s public and private investment expertise is distinctive in the health care space. Watch the video to learn more.
Stay up to date with the latest market insights and our point of view.
Venture capital outlook for 2026: 5 key trends
We explore 2026's venture capital trends, highlighting IPO momentum, M&A acceleration, secondary market growth, public-private convergence, and the focus on quality investments.
Human capital management for private companies
We discuss why effective people management is critical for private companies and outline four strategic focus areas that can help companies navigate evolving employee needs, regulatory changes, and investor expectations.
Venture and growth equity: The future of private-market evergreen funds?
Investment Director Cara Hubbard highlights how the VC and growth equity landscapes are transforming, details the rising popularity of evergreen funds, and shares how these themes may converge to expand access to private markets.
Collaboration in practice: Late-stage growth
Matt Witheiler, Head of Late-stage Growth, explores the impact of Wellington’s collaborative culture. He highlights the potential benefits of working with his private-market colleagues across sectors and stages as well as leveraging Wellington’s hundreds of public-market experts.
Collaboration in practice: Late-stage biotech
Nilesh Kumar, Head of Biotech Private Investing, explores how working with Wellington’s public-market biotech experts helps his team better understand the feasibility of emerging biotech innovations.
Collaboration in practice: Climate venture capital
Greg Wasserman, Head of Private Climate Investing, highlights the importance of collaborating with Wellington’s later-stage private market investors and public market experts to better understand best practices, valuation, exit opportunities, and more.
Collaboration in practice: Early-stage venture
Jackson Cummings, head of Wellington Access Ventures, outlines how collaborating with our later-stage private teams, public market industry analysts, and Value Creation Team can benefit his early-stage venture team.
Wellington Venture Summit
The Wellington Venture Summit brings our portfolio companies the breadth of our investment expertise and networks under one roof. Watch highlights from the summit on preparing to go public, fundraising your next round, and much more.
The transformative power of vertical AI agents
Olivia Hurley and Rie Kimoto explore Japan's banking sector, highlighting regional banks' undervaluation and M&A opportunities driven by regulatory changes and demographic shifts.
IPOs aren’t dead, they’re just napping
Experts from our venture capital and trading teams explore the current IPO landscape. They highlight three challenges and three opportunities for private companies aiming to go public today.
Building the future: Advances in AI infrastructure for autonomous agents
Van Jones highlights AI infrastructure advancements, emphasizing emerging protocols and data solutions for autonomous agents driving innovation and connectivity.
URL References
Related Insights